Facebook-f Instagram Twitter Youtube Whatsapp Tiktok Linkedin
Contact Us
iden

Prodia ProStem

Prostem is committed to becoming a leading stem cell company in terms of quality and service both in Indonesia and Asia.
ISCT 2020: POTENSI EXTRACELLULAR VESICLES (EV) UNTUK TERAPI KLINIS
August 10, 2020
Pembahasan topik yang disampaikan oleh ISCT pada tahun ini tidak hanya sebatas mengenai ...
Read More
ISCT 2020: PENDEMI GLOBAL SARS-COV2, HARAPAN & TERAPI PENYEMBUHANNYA
July 29, 2020
ISCT 2020 kali ini harus dilaksanakan secara virtual, seminar internasional tahunan ini rencananya ...
Read More
ISCT 2020: MESENCHYMAL STROMAL CELLS: FULL CIRCLE FROM BASIC RESEARCH INSIGHTS TO CLINICAL TRIAL UPDATES
July 28, 2020
ISCT virtual meeting 2020 membahas beberapa topik menarik yang berhubungan dengan Mesenchymal Stem ...
Read More
ProSTEM sebagai Member Aktif di Berbagai Organisasi Stem Cell Nasional & Internasional
July 8, 2020
Sebagai bentuk komitmen ProSTEM untuk selalu meng-update ilmu pengetahuan, ProSTEM selalu aktif mengikuti ...
Read More
CASE REPORT: EFFECT OF CONDTIONED MEDIUM NASAL DROP (CMND) AND INTRAVENOUS UMBILICAL CORD-MESENCHYMAL STEM CELL (UC-MSCSIV) ON THE FUNCTION OF CARDIO RESPIRATION AFTER 4 YEARS PERCUTANEOUS CORONARY INTERVENTION (PCI) IN RSPAD GATOT SOEBROTO
July 3, 2020
Read More
THE ROLE OF GROWTH MEDIUM IN THE POTENCY OF EPC-TYPE 2 DIABETES PATIENTS (A STUDY OF ALDHBRIGHT AS A MARKER OF THE POTENCY OF EPC)
July 3, 2020
Read More
CASE REPORT: SAFETY PROFILE AND EFFICACY OF ALLOGENEIC UMBILICAL CORD-MESENCHYMAL STEM CELLS THERAPY VIA INTRACORONARY ROUTE FOR ACUTE MYOCARDIAL INFARCTION
July 3, 2020
Read More
QUARANTINE TIME VALIDATION FOR UC-MSC ISOLATION
July 3, 2020
Read More
EFFECTIVENESS OF ALLOGENIC UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL THERAPY IN PERIPHERAL ARTERIAL DISEASE PATIENT: A CASE STUDY
July 3, 2020
Read More

Populer

Terbaru

Scroll to Top
Contact Us
[email protected]
+62 821 1212 1416
+62 21 230 2629
+62 21 230 2642